Talking Capital

Talking Capital

by

Talking Capital explores the big questions facing sophisticated, long-term investors. Join Ian Barnard and Robert Sears of Capital Generation Partners on a fortnightly basis, as they answer market and investment questions posed by our own clients, covering any asset class in any region of the world. Capital Generation Partners LLP is authorised and regulated by the Financial Conduct Authority and is registered as an Investment Adviser by the US Securities and Exchange Commission. All information and opinions expressed during this podcast are subject to change without notice. Advice is given and services are supplied by Capital Generation Partners LLP and its affiliates (“CapGen”) on the basis of our terms and conditions of business, which are available upon request. No liability is accepted or responsibility assumed in respect of persons who are not clients of CapGen, unless expressly agreed in writing. This podcast does not constitute investment advice or an offer, contract or other solicitation to purchase any assets or investment solutions or a recommendation to buy or sell any particular asset, security, strategy or investment product. Nothing said during this webinar should be construed as an invitation or inducement to engage in investment activity. More information: https://www.capgenpartners.com/legal/privacy-notice

Recent Episodes

  • US election market impacts and opportunities in commodities

    5 days ago
  • Earnings season, US growth momentum and inflation divergence

    3 weeks ago
  • Middle East escalations, the outlook for gold, and the China stimulus package

    1 month ago
  • Private Equity special: finding, assessing and accessing top managers

    2 months ago
  • Signal vs. noise: what the summer showed us, interest rates, and private equity

    2 months ago
  • Economic slowdown vs AI revolution: three potential paths for the global economy

    3 months ago
  • Navigating geopolitics, market concentration and Q2 markets wrap

    4 months ago
  • BioTech Special: trends, opportunities and the discipline of manager selection

    5 months ago
  • Oil prices, UK equities and the outlook for BioTech

    5 months ago
  • US consumption, 'Dr Copper' and the legacy of Jim Simons

    6 months ago